GRN No. 94

Docosahexaenoic acid-rich oil from tuna (DHA-rich tuna oil) and arachidonic acid-rich oil from Mortierella alpina (AA-rich fungal oil)

• Intended Use: Provide arachidonic acid (AA) at a mean level of 0.4 percent of total fatty acids and docosahexaenoic acid (DHA) at a mean level of 0.25 percent of total fatty acids in preterm infant formula used by hospitalized premature infants; AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in preterm infant formula used by post-discharge premature infants; and AA at a mean level of 0.4 percent of total fatty acids and DHA at a mean level of 0.15 percent of total fatty acids in term infant formula
• Basis: Scientific procedures
• Notifier: Ross Products Division, Abbott Laboratories
• Notifier Address: 625 Cleveland Avenue, Columbus, OH 43215-1724
• Date of filing: Jan 2, 2002
• GRAS Notice (releasable information): GRN 94 part 1 (in PDF) (13.0 MB)
• Part 2: GRN 94 part 2 (in PDF) (16.1 MB)
• Date of closure: Apr 18, 2006
• FDA's Letter: FDA has no questions